Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: A progress report
- 1 August 2007
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 222 (3), 388-398
- https://doi.org/10.1016/j.taap.2007.03.021
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell cultureToxicology and Applied Pharmacology, 2006
- Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical RemedyClinical Lymphoma Myeloma and Leukemia, 2006
- Probing the Control Elements of the CYP1A1 Switching Module in H4IIE Hepatoma CellsToxicological Sciences, 2005
- A Numerical Solution to the Nonhomogeneous Two‐Stage MVK Model of CancerRisk Analysis, 2005
- Quantitative Estimates of Risk for Noncancer EndpointsRisk Analysis, 2005
- New directions in incidence–dose modelingTrends in Biotechnology, 2005
- Human Respiratory Tract Cancer Risks of Inhaled Formaldehyde: Dose-Response Predictions Derived From Biologically-Motivated Computational Modeling of a Combined Rodent and Human DatasetToxicological Sciences, 2004
- Biologically Motivated Computational Modeling of Formaldehyde Carcinogenicity in the F344 RatToxicological Sciences, 2003
- Requirements for a Biologically Realistic Cancer Risk Assessment for Inorganic ArsenicInternational Journal of Toxicology, 1999
- Is Ingested Inorganic Arsenic a “Threshold” Carcinogen?Fundamental and Applied Toxicology, 1996